LabVantage Announces Product Enhancements

LabVantage Solutions announced three enhancements to its laboratory information management systems (LIMS) offerings in a virtual press conference on March 8, 2021, part of Pittcon 2021.

The company has added validation to three of its subscription-based software-as-a-service (SaaS) LIMS for regulated sectors, including the pharmaceutical industry. LabVantage Pharma, LabVantage Biobanking, and LabVantage COVID-19 LIMS now offer SaaS validation.

Evidence of validated control provides a record that the software is held to a set standard for data integrity and control and the responsibility rests with the vendor.

Customers pay an annual subscription fee to access the LabVantage LIMS, electronic laboratory notebook, laboratory execution system, and scientific data management system. Validated software updates are implemented by the company. A vendor-validated SaaS LIMS allows customers to expand the system to other locations, subsidiaries, and partners, the company reported.

The company also announced the launch of LabVantage Analytics, a self-service advanced analytics solution that allows users to explore, analyze, and visualize LIMS, enterprise, and external data for business insights. The offering integrates with the LabVantage LIMS platform

LabVantage Analytics enables laboratory managers and business colleagues both inside and outside the lab control of LIMS data together with relevant business and external data.

The tool analyzes structured and unstructured data from different sources, combining data ingestion, pre-processing, storage, analysis, and visualization into one application. Customizable dashboards and LIMS data reports enable users to access needed information.

In a third announcement, the company reported that LabVantage LIMS 8.6 has been designed and tested to optimum cybersecurity standards. The company has adopted SonarQube to scan source code for potential vulnerabilities; the use of Atlassian’s Jira software to track code and increase the visibility of security issues during development; and partnering with a third-party cybersecurity organization to test the software.

LabVantage LIMS features configurable security protocols and permissions that meet the requirements of the US Health Insurance Portability and Accountability Act, and the EU’s General Data Protection Regulation. Encryption is included in multiple stages and the company reports that it has been proactive in ensuring security through penetration testing and other activities to combat cyberattacks.

Source: LabVantage